SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 5, Issue 4, 2016, Pages

Prospective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancer

(2) Valmori, Danila a,b Ayyoub, Maha a

a INSERM (France)

b UNIVERSITÉ DE NANTES (France)

Author keywords

EGFR; immune therapy; KRAS; MAGE A; NSCLC; targeted therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IPILIMUMAB; K RAS PROTEIN; MELANOMA ANTIGEN;

ARTICLE; CELL TRANSFER; GENE MUTATION; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; NON SMALL CELL LUNG CANCER; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; VACCINATION;

EID: 84962836359 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/21624011.2014.947175 Document Type: Article

Times cited : (1)

References (10)

1
- 77953930730
- Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR
- 20573926
- M.Maemondo, A.Inoue, K.Kobayashi, S.Sugawara, S.Oizumi, H.Isobe, A.Gemma, M.Harada, H.Yoshizawa, I.Kinoshita, Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010; 362:2380-8; PMID:20573926; http://dx.doi.org/10.1056/NEJMoa0909530
- (2010) N Engl J Med , vol.362 , pp. 2380-2388
- Maemondo, M.¹ Inoue, A.² Kobayashi, K.³ Sugawara, S.⁴ Oizumi, S.⁵ Isobe, H.⁶ Gemma, A.⁷ Harada, M.⁸ Yoshizawa, H.⁹ Kinoshita, I.¹⁰

2
- 67349233828
- Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer
- 19062127
- K.Kakimi, J.Nakajima, H.Wada. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Lung Cancer 2009; 65:1-8; PMID:19062127; http://dx.doi.org/10.1016/j.lungcan.2008.10.018
- (2009) Lung Cancer , vol.65 , pp. 1-8
- Kakimi, K.¹ Nakajima, J.² Wada, H.³

3
- 84904112296
- Immunotherapy in the treatment of non-small cell lung cancer
- 24880938
- R.Sundar, R.Soong, B.C.Cho, J.R.Brahmer, R.A.Soo. Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer 2014; 85:101-109; PMID:24880938
- (2014) Lung Cancer , vol.85 , pp. 101-109
- Sundar, R.¹ Soong, R.² Cho, B.C.³ Brahmer, J.R.⁴ Soo, R.A.⁵

4
- 84863911486
- Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study
- 22547592
- T.J.Lynch, I.Bondarenko, A.Luft, P.Serwatowski, F.Barlesi, R.Chacko, M.Sebastian, J.Neal, H.Lu, J.M.Cuillerot, Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol 2012; 30:2046-54; PMID:22547592; http://dx.doi.org/10.1200/JCO.2011.38.4032
- (2012) J Clin Oncol , vol.30 , pp. 2046-2054
- Lynch, T.J.¹ Bondarenko, I.² Luft, A.³ Serwatowski, P.⁴ Barlesi, F.⁵ Chacko, R.⁶ Sebastian, M.⁷ Neal, J.⁸ Lu, H.⁹ Cuillerot, J.M.¹⁰

5
- 80053648839
- Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
- 21933959
- J.Yuan, M.Adamow, B.A.Ginsberg, T.S.Rasalan, E.Ritter, H.F.Gallardo, Y.Xu, E.Pogoriler, S.L.Terzulli, D.Kuk, Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A 2011; 108:16723-8; PMID:21933959; http://dx.doi.org/10.1073/pnas.1110814108
- (2011) Proc Natl Acad Sci U S A , vol.108 , pp. 16723-16728
- Yuan, J.¹ Adamow, M.² Ginsberg, B.A.³ Rasalan, T.S.⁴ Ritter, E.⁵ Gallardo, H.F.⁶ Xu, Y.⁷ Pogoriler, E.⁸ Terzulli, S.L.⁹ Kuk, D.¹⁰

6
- 0036813331
- Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
- 12445278
- M.J.Scanlan, A.O.Gure, A.A.Jungbluth, L.J.Old, Y.T.Chen. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188:22-32; PMID:12445278; http://dx.doi.org/10.1034/j.1600-065X.2002.18803.x
- (2002) Immunol Rev , vol.188 , pp. 22-32
- Scanlan, M.J.¹ Gure, A.O.² Jungbluth, A.A.³ Old, L.J.⁴ Chen, Y.T.⁵

7
- 84880507665
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- 23770567
- M.S.Lawrence, P.Stojanov, P.Polak, G.V.Kryukov, K.Cibulskis, A.Sivachenko, S.L.Carter, C.Stewart, C.H.Mermel, S.A.Roberts, Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499:214-8; PMID:23770567; http://dx.doi.org/10.1038/nature12213
- (2013) Nature , vol.499 , pp. 214-218
- Lawrence, M.S.¹ Stojanov, P.² Polak, P.³ Kryukov, G.V.⁴ Cibulskis, K.⁵ Sivachenko, A.⁶ Carter, S.L.⁷ Stewart, C.⁸ Mermel, C.H.⁹ Roberts, S.A.¹⁰

8
- 79959254308
- Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy
- A.Hamai, K.Duperrier-Amouriaux, P.Pignon, I.Raimbaud, L.Memeo, C.Colarossi, V.Canzonieri, T.Perin, J.M.Classe, M.Campone, Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy. PLoS One 2011; 6:e21129.
- (2011) PLoS One , vol.6 , pp. e21129
- Hamai, A.¹ Duperrier-Amouriaux, K.² Pignon, P.³ Raimbaud, I.⁴ Memeo, L.⁵ Colarossi, C.⁶ Canzonieri, V.⁷ Perin, T.⁸ Classe, J.M.⁹ Campone, M.¹⁰

9
- 84937511495
- Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathological features and mutational status of EGFR and KRAS
- In press, 24866168
- M.Ayyoub, L.Memeo, E.Alvarez-Fernandez, C.Colarossi, R.Costanzo, E.Aiello, D.Martinetti, D.Valmori. Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathological features and mutational status of EGFR and KRAS. Cancer Immunol Res 2014; In press; PMID:24866168
- (2014) Cancer Immunol Res
- Ayyoub, M.¹ Memeo, L.² Alvarez-Fernandez, E.³ Colarossi, C.⁴ Costanzo, R.⁵ Aiello, E.⁶ Martinetti, D.⁷ Valmori, D.⁸

10
- 23044462228
- XAGE-1 expression in non-small cell lung cancer and antibody response in patients
- 16061866
- K.Nakagawa, Y.Noguchi, A.Uenaka, S.Sato, H.Okumura, M.Tanaka, M.Shimono, A.M.Ali Eldib, T.Ono, N.Ohara, XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin Cancer Res 2005; 11:5496-503; PMID:16061866; http://dx.doi.org/10.1158/1078-0432.CCR-05-0216
- (2005) Clin Cancer Res , vol.11 , pp. 5496-5503
- Nakagawa, K.¹ Noguchi, Y.² Uenaka, A.³ Sato, S.⁴ Okumura, H.⁵ Tanaka, M.⁶ Shimono, M.⁷ Ali Eldib, A.M.⁸ Ono, T.⁹ Ohara, N.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.